https://www.gavi.org/
3 days ago · Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
https://en.wikipedia.org/wiki/GAVI
GAVI, officially Gavi, the Vaccine Alliance[1] (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization) [2] is a public–private global health partnership with the goal of increasing access to immunization in poor countries. [3]
https://www.gavi.org/about-us
May 7, 2026 · Created in 2000, Gavi is an international organisation – a global Vaccine Alliance, bringing together public and private sectors with the shared goal of saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.
https://www.kff.org/global-health-policy/the-u-s-government-gavi-the-vaccine-alliance/
May 4, 2026 · Gavi, the Vaccine Alliance (Gavi) is an independent public-private partnership and multilateral funding mechanism that aims to expand global access to and use of vaccines, particularly among...
https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance/networks/vaccine-safety-net/vsn-members/gavi-the-vaccine-alliance
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunise a whole generation – over 822 million children – and prevented more than 14 million deaths, helping to halve child mortality in ...
https://www.vaccinealliance.org/general-information/about-alliance/governance/whoweare/
Jul 3, 2025 · GAVI, known formally as the Global Alliance for Vaccines and Immunization, brings together governments, UN agencies, donors, and industry partners with one shared goal: to make vaccines accessible to every child, everywhere.
https://www.facebook.com/GAVI/
There is currently no vaccine specifically designed to protect against Bundibugyo virus, but now, the world’s first vaccine candidate designed specifically to protect against Bundibugyo ebolavirus has entered human trials.
